Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder

被引:37
|
作者
Zhang, K. [1 ]
Li, X. [1 ]
Yin, G. [1 ]
Liu, Y. [2 ]
Niu, X. [1 ]
Hou, R. [1 ]
机构
[1] Shanxi Med Univ, Taiyuan City Ctr Hosp, Inst Dermatol, Taiyuan 030009, Shanxi Prov, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Chinese PLA, Inst Dermatol, Xian 710032, Shaanxi Prov, Peoples R China
关键词
CD34+cells; haematopoietic cells; psoriasis; regulatory T cells; T lymphocytes;
D O I
10.1111/j.1365-2133.2007.08359.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background In psoriasis CD4+CD25+ regulatory T cells are functionally deficient. The imbalance between regulatory and effector T-cell functions is important for inducing psoriasis. It is reasonable to speculate that the dysfunctional activity of CD4+CD25+ regulatory cells may originate partly from the abnormal haematopoietic cells determined mainly by genetic background. Objectives To test the hypothesis that haematopoietic stem cells are responsible for dysfunctional CD4+CD25+ regulatory cells in psoriasis. Methods Bone marrow-derived CD34+ haematopoietic cells from patients with psoriasis (with a family history of psoriasis) and from normal controls were differentiated into T cells in vitro. CD4+CD25+ T cells were isolated by an immunomagnetic bead method, and proliferation activity and capacity for cytokine secretion were determined. Furthermore, the ability of CD4+CD25+ T cells to suppress the proliferative responses of allogeneous peripheral blood CD4+CD25- effector T cells was assessed in vitro. Results The differentiated CD4+CD25+ T cells of psoriatic origin showed similar characteristics to those of normal volunteers, including proliferation activity and secretion profile of the cytokines interleukin (IL)-2, IL-4, IL-8, IL-10 and interferon (IFN)-gamma. However, proliferation and secretion levels of the cytokines IL-2 and IL-10 for CD4+CD25+ cells of psoriatic CD34+ cell origin were significantly lower than those of normal controls in response to streptococcal superantigen (Strep-A). In particular, CD4+CD25+ T cells differentiated from psoriatic CD34+ cells were functionally insufficient to restrain effector T-cell proliferation. Conclusions CD4+CD25+ T cells differentiated in vitro from haematopoietic cells of patients with psoriasis are impaired in regulatory function. The dysfunction of psoriatic CD4+CD25+ T cells may be due to inherent genetic programming passed down from bone marrow-derived haematopoietic cells.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 50 条
  • [1] Functional characterization of T cells differentiated in vitro from bone marrow-derived CD34+cells of psoriatic patients with family history
    Zhang, Kaiming
    Li, Xinhua
    Yin, Guohua
    Liu, Yufeng
    Tang, Xuyuan
    [J]. EXPERIMENTAL DERMATOLOGY, 2010, 19 (08) : E128 - E135
  • [2] In vitro generation of CD4+CD25+ regulatory cells from murine naive T cells
    Massimo C Fantini
    Sabine Dominitzki
    Angelo Rizzo
    Markus F Neurath
    Christoph Becker
    [J]. Nature Protocols, 2007, 2 : 1789 - 1794
  • [3] Immunomodulation after allogeneic bone marrow transplantation by CD4+CD25+ regulatory T cells
    Hoffmann, P
    Boeld, TJ
    Piseshka, B
    Edinger, M
    [J]. MICROBES AND INFECTION, 2005, 7 (7-8) : 1066 - 1072
  • [4] The role of CD4+CD25+ T regulatory (TREG) cells in allogeneic bone marrow transplantation
    Blazar, BR
    Panoskaltsis-Mortari, A
    Levine, BL
    June, CH
    Lucas, PJ
    Gress, R
    Serody, JS
    Taylor, PA
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (10) : 737 - 737
  • [5] Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function
    Brinster, C
    Shevach, EM
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (11): : 7332 - 7340
  • [6] Phenotypic characterization of regulatory CD4+CD25+ T cells in rats
    Stephens, LA
    Barclay, AN
    Mason, D
    [J]. INTERNATIONAL IMMUNOLOGY, 2004, 16 (02) : 365 - 375
  • [7] Proteomic characterization of murine CD4+CD25+ regulatory T cells
    Rovis, F
    Wait, R
    Lee, BBC
    Monk, CR
    Lechler, RI
    Garden, OA
    [J]. IMMUNOLOGY 2004: GENOMIC ISSUES, IMMUNE SYSTEM ACTIVATION AND ALLERGY, 2004, : 79 - 84
  • [8] Human CD4+CD25+ regulatory T cells
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    [J]. SEMINARS IN IMMUNOLOGY, 2004, 16 (02) : 89 - 97
  • [9] CD4+CD25+ T cells as immunoregulatory T cells in vitro
    Chai, JG
    Tsang, JYS
    Lechler, R
    Simpson, E
    Dyson, J
    Scott, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (08) : 2365 - 2375
  • [10] CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation
    Joffre, O
    van Meerwijk, JPM
    [J]. SEMINARS IN IMMUNOLOGY, 2006, 18 (02) : 128 - 135